Last reviewed · How we verify
NCT05321095: SALINE
Screening for Albuminuria at the First Line for Early Identification of CKD
trial testing Albuminuria test in Chronic Kidney Diseases in 141 participants. Completed in 30 July 2024.
31 December 2023
Quick facts
| Lead sponsor | General Practitioners Research Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 141 |
| Start date | 25 November 2021 |
| Primary completion | 31 December 2023 |
| Estimated completion | 30 July 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Albuminuria test
- HbA1c test
- Creatinine test
Conditions studied
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
- Albuminuria — all drugs for Albuminuria →
Sponsor
General Practitioners Research Institute
Who can join
Adults 18 to 80, any sex, with Chronic Kidney Diseases or Albuminuria. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Early detection of kidney disease
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of a systematic home-based albuminuria screening programme to detect chronic kidney disease in high-risk individuals in primary care (SALINE): a cross-sectional screening study.
van Mil D, Kieneker LM, Harms E, Prins GH, et al · · 2025 · cited 2× · PMID 40247889 · DOI 10.1016/j.eclinm.2025.103185
Verify or expand the search:
- PubMed search for NCT05321095
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Diseases
Currently open trials in the same condition.
- NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
- NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
- NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
- NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
- NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting
Other General Practitioners Research Institute trials
Trials by the same sponsor.
- NCT07390669 — OptimAIR: Towards Right Care in Asthma Through Point-of-care Phenotyping, Guideline-based Assessment and Management Opti · NA · active not recruiting
- NCT06659666 — The COPD Optimiser · completed
- NCT06398821 — G3P-01 in Volunteers With Elevated Galectin-3 · Phase 2 · completed
- NCT05162157 — Home Spirometry in Primary Care: an Implementation Study · completed
- NCT04539457 — Managing Appropriate Prescribing in COPD · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05321095 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Practitioners Research Institute
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05321095.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing